FLNA

FILANA THERAPEUTICS, INC. FLNA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$15.09M total
VANGUARD CAPITAL MANAGEMENT LLC
$2.35M+2.3%
TWO SIGMA INVESTMENTS, LP
$2.04M-14.0%
MARSHALL WACE, LLP
$1.90M-20.6%
BlackRock, Inc.
$1.73M+2.8%
GOLDMAN SACHS GROUP INC
$795.9K+1518.4%
GEODE CAPITAL MANAGEMENT, LLC
$732.7K+3.2%
D. E. Shaw & Co., Inc.
$577.2K-13.3%
GMT CAPITAL CORP
$535.6K0.0%
RENAISSANCE TECHNOLOGIES LLC
$463.6K+19.2%
Squarepoint Ops LLC
$378.9KNew
VANGUARD FIDUCIARY TRUST CO
$375.9K+15.3%
ACADIAN ASSET MANAGEMENT LLC
$350.0K+3.8%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$347.5K-34.7%
GSA CAPITAL PARTNERS LLP
$321.0K+23.7%
GROUP ONE TRADING, L.P.
$290.4K-19.4%
STATE STREET CORP
$248.8K-12.9%
VANGUARD PORTFOLIO MANAGEMENT LLC
$157.8K-0.1%
Connor, Clark & Lunn Investment Management Ltd.
$157.4K-3.4%
FEDERATED HERMES, INC.
$142.7K+4.2%
NORTHERN TRUST CORP
$136.0K-23.4%
SIMPLEX TRADING, LLC
$118.9K-28.7%
STIFEL FINANCIAL CORP
$89.3KNew
XTX Topco Ltd
$76.9K+94.0%
JANE STREET GROUP, LLC
$70.2K-73.8%
Verition Fund Management LLC
$55.8K+22.9%
See all 86 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/FLNA

Earnings Per Share

13fpro.ai/company/FLNA

Loading ratio trend…

FLNA key financials by period

Reported revenue, net income and operating margin by fiscal year, from FILANA THERAPEUTICS, INC.'s annual filings on SEC EDGAR.

FILANA THERAPEUTICS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2013$41.1M$31.5M76.3%
FY 2012$10.9M$-3.4M-35.8%
FY 2011$11.5M$-2.6M-30.6%
FY 2010$16.8M$-12.0M-81.5%
FY 2009$20.6M$-3.5M-32.9%
Source: FLNA filings on SEC EDGAR →

FLNA insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About FILANA THERAPEUTICS, INC. (FLNA): stock profile, AI score and financials

FILANA THERAPEUTICS, INC. (FLNA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. FLNA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of FLNA by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, TWO SIGMA INVESTMENTS, MARSHALL WACE, LLP, based on the most recent SEC filings. FLNA trades on the Nasdaq exchange and files with the SEC under CIK 1069530. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FLNA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FILANA THERAPEUTICS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1069530 →